Affichage 1 à 10 des 15 essais cliniques
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Investigateur(trice) principal(e)
Coordonnateur(rice) |
||
---|---|---|---|
Étude en deux parties, ouverte et randomisée de phase II/III visant à comparer un traitement par dinutuximab et irinotécan avec un traitement par irinotécan seul pour le traitement de deuxième ligne chez des sujets atteints de cancer du poumon à petites cellules résistant ou récidivant.
Distinct / DIV-SCLC-301 NCT03098030 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Poumon à petites cellules |
Dre Vera Hirsh Nicola Raby 514-934-1934 poste 34095 |
(EN) A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
ADRIATIC NCT03703297 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Poumon à petites cellules |
Dr Scott Owen Corneille Bashagaluke 514-934-1934 poste 34907 |
(EN) MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer
BRC.8 / SWOG S1827 (MAVERICK) NCT04155034 ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Poumon à petites cellules |
Dre Caroline Lavoie Josée Allard 418-525-4444 poste 16730 |
(EN) Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca
EMERGE 402 (JZP712-402) NCT04894591 ![]() |
CISSS DU BAS-SAINT-LAURENT
![]() |
Poumon à petites cellules |
Dr Samuel Nadeau Marie-Eve Fournier 418-724-3000 poste 8029 |
(EN) MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer
BRC.8 / SWOG S1827 (MAVERICK) NCT04155034 ![]() |
CIUSSS DE LA MAURICIE-ET-DU-CENTRE-DU-QUEBEC
![]() |
Poumon à petites cellules |
Dr François Vincent Marie-Ève Caron 819-697-3333 poste 63238 |
(EN) Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca
EMERGE 402 (JZP712-402) NCT04894591 ![]() |
CISSS DE CHAUDIERE-APPALACHES
![]() |
Poumon à petites cellules |
Dre Danièle Marceau Pierre Bédard 418-835-7121 |
(EN) Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca
EMERGE 402 (JZP712-402) NCT04894591 ![]() |
INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUEBEC - UL
|
Poumon à petites cellules |
Dre Catherine Labbé Brigitte Fortin 418-656-8711 poste 2639 |
(EN) Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca
EMERGE 402 (JZP712-402) NCT04894591 ![]() |
CIUSSS DU SAGUENAY – LAC-SAINT-JEAN
![]() |
Poumon à petites cellules |
Dr José Luiz Miranda Guimaraes Pascale Duchesne 418-541-1000 poste 2840 |
(EN) A Phase 1b/2 Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Investigational Agents for the Treatment of Participants With PD-1/L1-refractory Extensive-Stage Small Cell Lung Cancer in Need of Second-Line Therapy
MK-3475-B98/KEYNOTE-B98 NCT04938817 ![]() |
CIUSSS DE L'OUEST-DE-L'ILE-DE-MONTREAL
![]() |
Poumon à petites cellules |
Dr Adrian Langleben Rachelle Dumas 514-345-3511 poste 3378 |
(EN) A Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Etoposide and Cisplatin or Carboplatin for the First-Line Treatment of Participants With Extensive-Stage Small Cell Lung Cancer
MK-3475-B99/ KEYNOTE-B99 NCT04924101 ![]() |
CIUSSS DE L'OUEST-DE-L'ILE-DE-MONTREAL
![]() |
Poumon à petites cellules |
Dr Adrian Langleben Mitra Vaezi 514-345-3511 poste 3981 |